Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

A systematic review of the safety of topical therapies for atopic dermatitis.

Callen J, Chamlin S, Eichenfield LF, Ellis C, Girardi M, Goldfarb M, Hanifin J, Lee P, Margolis D, Paller AS, Piacquadio D, Peterson W, Kaulback K, Fennerty M, Wintroub BU.

Br J Dermatol. 2007 Feb;156(2):203-21. Review.

2.

Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.

Draelos ZD.

Curr Med Res Opin. 2008 Apr;24(4):985-94. doi: 10.1185/030079908X280419 . Epub 2008 Feb 18. Review.

PMID:
18284804
3.

Atopic dermatitis: understanding the disease and its management.

Levy ML.

Curr Med Res Opin. 2007 Dec;23(12):3091-103. Review.

PMID:
17971284
4.

Atopic dermatitis: a review of topical treatment options.

Simpson EL.

Curr Med Res Opin. 2010 Mar;26(3):633-40. doi: 10.1185/03007990903512156. Review.

PMID:
20070141
5.

Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W.

Pharmacoeconomics. 2003;21(3):159-79. Review.

PMID:
12558467
6.

Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.

Green C, Colquitt JL, Kirby J, Davidson P.

Br J Dermatol. 2005 Jan;152(1):130-41. Review.

PMID:
15656813
7.

Recent advances in treatment strategies for atopic dermatitis.

Roos TC, Geuer S, Roos S, Brost H.

Drugs. 2004;64(23):2639-66. Review.

PMID:
15537368
8.
9.

Systemic therapy of atopic dermatitis in children.

Ricci G, Dondi A, Patrizi A, Masi M.

Drugs. 2009;69(3):297-306. doi: 10.2165/00003495-200969030-00005. Review.

PMID:
19275273
10.

Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.

Pariser D.

Am J Ther. 2009 May-Jun;16(3):264-73. doi: 10.1097/MJT.0b013e31818a975c. Review.

PMID:
19262357
11.
12.

The socioeconomic impact of atopic dermatitis in the United States: a systematic review.

Mancini AJ, Kaulback K, Chamlin SL.

Pediatr Dermatol. 2008 Jan-Feb;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x. Review.

PMID:
18304144
13.

Corticosteroids: options in the era of steroid-sparing therapy.

Del Rosso J, Friedlander SF.

J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. Review.

PMID:
15968264
14.

Treatment options for atopic dermatitis.

Buys LM.

Am Fam Physician. 2007 Feb 15;75(4):523-8. Review.

15.

Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses.

Frangos JE, Kimball AB.

Expert Opin Pharmacother. 2008 Aug;9(11):2001-7. doi: 10.1517/14656566.9.11.2001 . Review.

PMID:
18627337
16.

Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Munzenberger PJ, Montejo JM.

Pharmacotherapy. 2007 Jul;27(7):1020-8. Review.

PMID:
17594208
17.

[The use of topical corticosteroids in atopic dermatitis in children].

Cambazard F.

Ann Dermatol Venereol. 2005 Jan;132 Spec No 1:1S64-7. Review. French.

PMID:
15984295
18.

Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Abramovits W, Hung P, Tong KB.

Am J Clin Dermatol. 2006;7(4):213-22. Review.

PMID:
16901181
19.

Calcineurin inhibitors in the treatment of allergic dermatitis.

Castro AP.

J Pediatr (Rio J). 2006 Nov;82(5 Suppl):S166-72. Review.

20.

Therapeutic options in the treatment of psoriasis and atopic dermatitis.

Gottlieb AB.

J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S3-16. Review.

PMID:
15968262

Supplemental Content

Support Center